Annual EBITDA
-$6.41 M
+$9.61 M+59.99%
December 31, 2023
Summary
- As of February 7, 2025, CLGN annual EBITDA is -$6.41 million, with the most recent change of +$9.61 million (+59.99%) on December 31, 2023.
- During the last 3 years, CLGN annual EBITDA has fallen by -$1.47 million (-29.78%).
- CLGN annual EBITDA is now -864.92% below its all-time high of $838.00 thousand, reached on December 31, 2021.
Performance
CLGN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$4.29 M
-$142.00 K-3.43%
September 30, 2024
Summary
- As of February 7, 2025, CLGN quarterly EBITDA is -$4.29 million, with the most recent change of -$142.00 thousand (-3.43%) on September 30, 2024.
- Over the past year, CLGN quarterly EBITDA has increased by +$43.00 thousand (+0.99%).
- CLGN quarterly EBITDA is now -142.03% below its all-time high of $10.20 million, reached on March 1, 2021.
Performance
CLGN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$17.27 M
+$43.00 K+0.25%
September 30, 2024
Summary
- As of February 7, 2025, CLGN TTM EBITDA is -$17.27 million, with the most recent change of +$43.00 thousand (+0.25%) on September 30, 2024.
- Over the past year, CLGN TTM EBITDA has dropped by -$11.26 million (-187.37%).
- CLGN TTM EBITDA is now -357.61% below its all-time high of $6.70 million, reached on March 1, 2021.
Performance
CLGN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CLGN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +60.0% | +1.0% | -187.4% |
| 3 y3 years | -29.8% | +1.0% | -187.4% |
| 5 y5 years | -64.2% | +1.0% | -187.4% |
CLGN EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -864.9% | +60.0% | -172.1% | +10.4% | -2160.3% | +0.3% |
| 5 y | 5-year | -864.9% | +60.0% | -142.0% | +10.4% | -357.6% | +0.3% |
| alltime | all time | -864.9% | +60.0% | -142.0% | +10.4% | -357.6% | +0.3% |
CollPlant Biotechnologies EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$4.29 M(+3.4%) | -$17.27 M(-0.2%) |
| Jun 2024 | - | -$4.14 M(+2.4%) | -$17.31 M(+139.7%) |
| Mar 2024 | - | -$4.05 M(-15.4%) | -$7.22 M(+12.6%) |
| Dec 2023 | -$6.41 M(-60.0%) | -$4.78 M(+10.5%) | -$6.41 M(+6.7%) |
| Sep 2023 | - | -$4.33 M(-172.9%) | -$6.01 M(+2.4%) |
| Jun 2023 | - | $5.94 M(-283.5%) | -$5.87 M(-62.7%) |
| Mar 2023 | - | -$3.24 M(-26.1%) | -$15.73 M(-1.8%) |
| Dec 2022 | -$16.02 M(-2011.8%) | -$4.38 M(+4.7%) | -$16.02 M(+5.3%) |
| Sep 2022 | - | -$4.19 M(+6.7%) | -$15.22 M(+9.3%) |
| Jun 2022 | - | -$3.92 M(+11.2%) | -$13.93 M(+8.1%) |
| Mar 2022 | - | -$3.53 M(-1.5%) | -$12.89 M(-1638.1%) |
| Dec 2021 | $838.00 K(-117.0%) | - | - |
| Dec 2021 | - | -$3.58 M(+23.6%) | $838.00 K(-54.6%) |
| Sep 2021 | - | -$2.90 M(+0.5%) | $1.85 M(-67.2%) |
| Jun 2021 | - | -$2.88 M(-128.3%) | $5.62 M(-16.1%) |
| Mar 2021 | - | $10.20 M(-496.5%) | $6.70 M(-235.9%) |
| Dec 2020 | -$4.94 M(-30.4%) | - | - |
| Dec 2020 | - | -$2.57 M(-391.9%) | -$4.93 M(+9.5%) |
| Sep 2020 | - | $881.00 K(-148.8%) | -$4.50 M(-35.9%) |
| Jun 2020 | - | -$1.81 M(+26.0%) | -$7.03 M(+11.0%) |
| Mar 2020 | - | -$1.43 M(-33.2%) | -$6.33 M(-2.0%) |
| Dec 2019 | -$7.09 M(+81.7%) | - | - |
| Dec 2019 | - | -$2.15 M(+30.5%) | -$6.46 M(+79.0%) |
| Sep 2019 | - | -$1.64 M(+48.0%) | -$3.61 M(+14.4%) |
| Jun 2019 | - | -$1.11 M(-28.8%) | -$3.16 M(-3.1%) |
| Mar 2019 | - | -$1.56 M | -$3.26 M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$3.90 M(-31.8%) | - | - |
| Dec 2018 | - | $705.00 K(-159.3%) | -$3.60 M(-41.3%) |
| Sep 2018 | - | -$1.19 M(-1.8%) | -$6.14 M(+3.3%) |
| Jun 2018 | - | -$1.21 M(-36.6%) | -$5.95 M(-5.5%) |
| Mar 2018 | - | -$1.91 M(+4.3%) | -$6.29 M(+10.4%) |
| Dec 2017 | -$5.73 M(-17.4%) | - | - |
| Dec 2017 | - | -$1.83 M(+84.6%) | -$5.70 M(+3.2%) |
| Sep 2017 | - | -$992.40 K(-36.3%) | -$5.53 M(-11.9%) |
| Jun 2017 | - | -$1.56 M(+18.2%) | -$6.28 M(-0.6%) |
| Mar 2017 | - | -$1.32 M(-20.3%) | -$6.32 M(-8.2%) |
| Dec 2016 | -$6.94 M(+50.2%) | - | - |
| Dec 2016 | - | -$1.66 M(-5.0%) | -$6.88 M(-2.3%) |
| Sep 2016 | - | -$1.74 M(+8.9%) | -$7.04 M(+10.2%) |
| Jun 2016 | - | -$1.60 M(-15.1%) | -$6.39 M(+12.0%) |
| Mar 2016 | - | -$1.88 M(+3.7%) | -$5.71 M(+22.8%) |
| Dec 2015 | -$4.62 M(+40.1%) | - | - |
| Dec 2015 | - | -$1.82 M(+66.7%) | -$4.65 M(+24.1%) |
| Sep 2015 | - | -$1.09 M(+18.8%) | -$3.75 M(+12.8%) |
| Jun 2015 | - | -$917.00 K(+11.3%) | -$3.32 M(+3.5%) |
| Mar 2015 | - | -$823.60 K(-10.0%) | -$3.21 M(+34.5%) |
| Dec 2014 | -$3.30 M(-25.9%) | - | - |
| Dec 2014 | - | -$915.20 K(+37.4%) | -$2.39 M(+62.2%) |
| Sep 2014 | - | -$666.10 K(-17.2%) | -$1.47 M(+82.8%) |
| Jun 2014 | - | -$804.60 K | -$804.60 K |
| Dec 2013 | -$4.45 M(+4.4%) | - | - |
| Dec 2012 | -$4.26 M | - | - |
FAQ
- What is CollPlant Biotechnologies annual EBITDA?
- What is the all time high annual EBITDA for CollPlant Biotechnologies?
- What is CollPlant Biotechnologies annual EBITDA year-on-year change?
- What is CollPlant Biotechnologies quarterly EBITDA?
- What is the all time high quarterly EBITDA for CollPlant Biotechnologies?
- What is CollPlant Biotechnologies quarterly EBITDA year-on-year change?
- What is CollPlant Biotechnologies TTM EBITDA?
- What is the all time high TTM EBITDA for CollPlant Biotechnologies?
- What is CollPlant Biotechnologies TTM EBITDA year-on-year change?
What is CollPlant Biotechnologies annual EBITDA?
The current annual EBITDA of CLGN is -$6.41 M
What is the all time high annual EBITDA for CollPlant Biotechnologies?
CollPlant Biotechnologies all-time high annual EBITDA is $838.00 K
What is CollPlant Biotechnologies annual EBITDA year-on-year change?
Over the past year, CLGN annual EBITDA has changed by +$9.61 M (+59.99%)
What is CollPlant Biotechnologies quarterly EBITDA?
The current quarterly EBITDA of CLGN is -$4.29 M
What is the all time high quarterly EBITDA for CollPlant Biotechnologies?
CollPlant Biotechnologies all-time high quarterly EBITDA is $10.20 M
What is CollPlant Biotechnologies quarterly EBITDA year-on-year change?
Over the past year, CLGN quarterly EBITDA has changed by +$43.00 K (+0.99%)
What is CollPlant Biotechnologies TTM EBITDA?
The current TTM EBITDA of CLGN is -$17.27 M
What is the all time high TTM EBITDA for CollPlant Biotechnologies?
CollPlant Biotechnologies all-time high TTM EBITDA is $6.70 M
What is CollPlant Biotechnologies TTM EBITDA year-on-year change?
Over the past year, CLGN TTM EBITDA has changed by -$11.26 M (-187.37%)